← Back to Search

Behavioural Intervention

inspiratory muscle program for Lung Cancer (CT0076 Trial)

N/A
Waitlist Available
Led By Moishe Liberman, MD, PhD
Research Sponsored by Centre hospitalier de l'Université de Montréal (CHUM)
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 30 days after surgery
Awards & highlights

CT0076 Trial Summary

This trial investigates whether a preoperative inspiratory muscle exercises program can reduce pulmonary complications after thoracic surgery.

Eligible Conditions
  • Lung Cancer

CT0076 Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 30 days after surgery
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 30 days after surgery for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Numbers of postoperative pulmonary complications
Secondary outcome measures
Length of stay (by days)
Numbers of morbidity and mortality

CT0076 Trial Design

2Treatment groups
Experimental Treatment
Group I: no inspiratory muscle programExperimental Treatment1 Intervention
standard of care: postoperative spirometry with enhanced recovery program in thoracic surgery
Group II: inspiratory muscle programExperimental Treatment1 Intervention
Inspiratory muscle training preoperative with standard of care

Find a Location

Who is running the clinical trial?

Centre hospitalier de l'Université de Montréal (CHUM)Lead Sponsor
366 Previous Clinical Trials
129,496 Total Patients Enrolled
Moishe Liberman, MD, PhDPrincipal InvestigatorCHUM
16 Previous Clinical Trials
1,090 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~23 spots leftby Apr 2025